To compare the safety and effectiveness of the study drug TAK-881 to the common drug HYQVIA.

To determine the safety and efficacy of GIE Medical's ProTractX3™ TTS DCB for the treatment of recurrent benign bowel strictures.

To explore community pharmacist perspectives on the feasibility of and interest in pharmacy-centered methadone access at rural community pharmacies. The model for which we will elicit pharmacists' perspectives parallels several similar successful programs that exist outside of the US and several successful small-scale pilots that have been conducted in urban areas of the US, including NC.

The purpose of this study is to understand more about the evolving practices of evangelical contemporary worship and perceptions of such practices by church leaders versus worship participants.

Mental health issues are rising among kids in the United States. Speaking to a counselor over video chat is one way to increase access to mental health care during mental health crises. This study looks at what kids, parents, and school staff think about using video chats with a counselor to help when kids have mental health crises at school.

This study aims to learn about how future teachers are trained to assess reading skills in elementary students. We want to understand their experiences, opinions, and confidence in using literacy assessments. By gathering this information, we hope to improve how teacher training programs prepare teachers to assess reading in young students.

We are hoping to have patient who under went doulbe-jaw surgery for obstructive sleep apnea fill out a survey to inform of us there experience, expectations, and results after surgery.

This clinical trial aims to understand how well ALXN-C5IT works over a long time. We want to see if it can prevent relapses and help with disability, walking, and vision. We also want to know how patients feel about their health while using ALXN-C5IT.

This is a clinical research study to learn more about a drug being developed to treat Hidradenitis Suppurativa. The study drug is called 'Povorcitinib.' We want to learn more about how this study drug affects those with Hidradenitis Suppurativa.

This is a clinical research study to learn more about a drug being developed to treat Non segmental vitiligo. The study drug is called 'Ritlecitinib.' We wanted to learn more about how this study drug affects those with Non segmental vitiligo.